Dr. Choi's lab focuses on the identification and validation of therapeutic targets for alcoholism and comorbid psychiatric disorders using cutting-edge technologies in the areas of neuroscience, animal behaviors and pharmacology.
Under the leadership of principal investigator Doo-Sup Choi, Ph.D., the Neurobiology of Alcoholism and Drug Addiction Laboratory focuses its research studies on the identification and validation of therapeutic targets for alcoholism and comorbid and co-occurring psychiatric disorders.
Dr. Choi's lab also applies state-of-the art integrative neurobiological and pharmacological techniques to the study of addictive behaviors. To understand molecular mechanisms underpinning alcoholism and comorbid psychiatric disorders, his team employs cutting-edged technologies and aspires to translate the findings into clinical usage.
Specific areas of research interest in our lab include:
Since its founding in 2005, the Neurobiology of Alcoholism and Drug Addiction Lab has been funded by the National Institutes of Health, along with other extramural funding sources.
Dr. Choi's lab is affiliated with these Mayo Clinic research areas:
Doo-Sup Choi, Ph.D., is a neuroscientist and Professor of Pharmacology and Psychiatry at Mayo Clinic in Rochester, Minnesota. He serves as the Director of the Samuel C. Johnson Genomics of Addiction Program and Director of the Mayo Rodent Behavior Facility at Mayo Clinic in Rochester, Minnesota.
Get in touch with the Neurobiology of Alcoholism and Drug Addiction Lab about its research projects and opportunities for collaboration, funding and training.
Learn about the lab's research projects.
Meet Dr. Choi's research team and stay connected with the lab's research findings through published articles.
Research positions are frequently available in Dr. Choi's Neurobiology of Alcoholism and Drug Addiction Lab.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?